Active — Not RecruitingNot Applicable

Multidisciplinary Intervention In Chronic GVHD

United States80 participantsStarted 2020-08-02

Plain-language summary

This research is being done to evaluate the feasibility and efficacy of a multidisciplinary, patient-centered intervention, Horizons Program, versus minimally enhanced standard care to improve quality of life, symptom burden and psychological distress of adults who received an allogeneic hematopoietic stem cell transplant and developed graft versus-host disease (GVHD).

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adult patients (≥ 21 years) who underwent allogeneic HCT * have moderate to severe chronic GVHD * are currently receiving their care at the MGH Blood and Marrow Transplant Clinic * have the ability to participate in an English language group intervention Exclusion Criteria: * Patients with comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention * Vulnerable patients, defined here as prisoners and pregnant women, will not be included in the intervention

What they're measuring

Rate of Enrollment

Timeframe: Baseline (pre-randomization) to 8 week follow up

Rate of adherence

Timeframe: Baseline (pre-randomization) to 8 week follow up

Rate of retention

Timeframe: Baseline (pre-randomization) to 8 week follow up

Trial details

NCT IDNCT04479995

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More Stem Cell Transplant Complications trials